| 摘要 |
Ready-to-use parenteral formulations of dezocine contain from about 0,2 to about 2,0 percent wt/vol. dezocine; about 30 to about 45 percent wt/vol. propylene glycol; about 0,5 to about 2,0 percent wt/vol. lactic acid; buffered with a pharmaceutically acceptable base to a pH of from about 3,5 to about 5,0 and 0 to about 0,02 percent wt/vol. sodium or potassium metabisulphite, in water for injection. |
